Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
Ticker SymbolCHEK
Company nameCheck Cap Ltd
IPO dateFeb 19, 2015
CEOMr. Alex Ovadia
Number of employees- -
Security typeOrdinary Share
Fiscal year-endFeb 19
Address29 Abba Hushi Ave.
City
Stock exchangeNASDAQ Capital Market Consolidated
CountryIsrael
Postal code3009000
Phone97248303401
Websitehttps://check-cap.com/
Ticker SymbolCHEK
IPO dateFeb 19, 2015
CEOMr. Alex Ovadia
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data